Abstract:Calcium-sensing receptors (CaSR) are G-protein coupled receptors which maintain systemic calcium haemeostasis, participate in hormone secretion, activation of iron channel, cell apoptosis, proliferation and differentiation. Previous studies have show CaSR induce apoptosis in isolated rat adult heart and in normal rat neonatal cardiomyocytes by G-protein-PLC-IP 3 signaling transinduction. A few of studies had demonstrated that CaSR induce apoptosis in cultured neonatal rat cardiomyocytes during ischemia/reperfusion. Hepatocyte growth factor (HGF), as a mesenchymally derived heterodimeric glycoprotein, play vital role in mitogenesis, angiogenesis, cellular motility and growth and anti-apoptosis after postinfarction heart failure via activation of transmembrane tyrosine kinase cell surface receptor c-Met. However, little knowledge exists about whether anti-apoptotic role of HGF in preventing cardiomyocytes injury induced by ischemia/reperfusion is associated with downregulation of CaSR expression. We incubated primary neonatal rat ventricular cardiomyocytes in ischemia-mimetic solution for 2 h, then reincubated them in normal culture medium for 24 h to establish a model of simulated ischemia/reperfusion (I/R). Cardiomyocyte apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. The expression of CaSR mRNA was detected by reverse transcriptase polymerase chain reaction (RT-PCR). In addition, we analyzed the expression of Caspase-3, Bcl-2 and Phosphoinositide 3-kinase (PI3K) by Western blotting. The simulated I/R enhances the expression of CaSR and cardiomyocyte apoptosis. GdCl 3 , a specific activator of CaSR, further increase the expression of CaSR and Cardiomyocyte apoptosis, along with upregulation of Caspase-3, downregulation of Bcl-2 and inhibiting PI3K phosphorylation. Combination of GdCl 3 with LY294002 (a selective PI3K inhibitor) increased Cardiomyocytes apoptosis but did not increased CaSR expression. Treatment of HGF decreased I/R- and GdCl 3 -induced apoptosis by suppressing Caspase-3 and promoting Bcl-2 and PI3K phosphorylation expression in accordance with downregulation of CaSR expression. HGF exerts protective role in I/R-induced apoptosis at least in part by inhibiting CaSR expression along with promoting Bcl-2, suppressing Caspase-3 expression and stimulating PI3K phosphorylation signaling pathway.

Locally Overexpressing Hepatocyte Growth Factor Prevents Post-Ischemic Heart Failure by Inhibition of Apoptosis Via Calcineurin-Mediated Pathway and Angiogenesis.

Effects of Hepatocyte Growth Factor Overexpressed Bone Marrow‐derived Mesenchymal Stem Cells on Prevention from Left Ventricular Remodelling and Functional Improvement in Infarcted Rat Hearts

Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.

Hepatocyte Growth Factor Intervention to Reduce Myocardial Injury and Improve Cardiac Function on Diabetic Myocardial Infarction Rats.

Hepatoma-Derived Growth Factor Secreted from Mesenchymal Stem Cells Reduces Myocardial Ischemia-Reperfusion Injury.

Treatment of Myocardial Ischemia with Bone Marrow-Derived Mesenchymal Stem Cells Overexpressing Hepatocyte Growth Factor

Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration Via PI3K/Akt and ERK1/2 Pathways

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

Mesenchymal Stem Cells Combined with Hepatocyte Growth Factor Therapy for Attenuating Ischaemic Myocardial Fibrosis: Assessment Using Multimodal Molecular Imaging

Exogenous HGF Prevents Cardiomyocytes from Apoptosis after Hypoxia Via Up-Regulating Cell Autophagy.

Therapeutic Potential of Angiogenin Modified Mesenchymal Stem Cells: Angiogenin Improves Mesenchymal Stem Cells Survival under Hypoxia and Enhances Vasculogenesis in Myocardial Infarction.

Role of hepatocyte growth factor on cardiomyocyte apoptosis and left ventricular remodeling after acute myocardial infarction

Inhibitory effect of hepatocyte growth factor on cardiomyocytes apoptosis is partly related to reduced calcium sensing receptor expression during a model of simulated ischemia/reperfusion

Mesenchymal Stem Cells Preconditioned with High Density Lipoprotein Resist Oxidative Stress-Induced Apoptosis and Improve Cardiac Function in A Rat Model of Myocardial Infarction

Cellular Repressor of E1A-stimulated Gene Overexpression in Bone Mesenchymal Stem Cells Protects Against Rat Myocardial Infarction.

Effects of Insulin-Like Growth Factor 1 on the Myocardium Regeneration and Anti-Inflammation in Mesenchymal Stem Cells

MSCs transplantation with application of G-CSF reduces apoptosis or increases VEGF in rabbit model of myocardial infarction

Insulin-Like Growth Factor 1 Treatment of MSCs Attenuates Inflammation and Cardiac Dysfunction Following MI

IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway

UPREGULATION OF HEME OXYGENASE-1 EXPRESSION IS ASSOCIATED WITH IMPROVEMENT OF CARDIAC FUNCTION AFTER HUMAN BONE MARROW MESENCHYMAL CELLS TRANSPLANTATION IN INFARCTED RAT

Overexpression of Csx/Nkx2.5 and GATA-4 Enhances the Efficacy of Mesenchymal Stem Cell Transplantation after Myocardial Infarction